CMT-3 targets different α-synuclein aggregates mitigating their toxic and inflammogenic effects.
González-Lizárraga F, Ploper D, Ávila CL, Socías SB, Dos-Santos-Pereira M, Machín B, Del-Bel E, Michel PP, Pietrasanta LI, Raisman-Vozari R, Chehín R.
González-Lizárraga F, et al.
Sci Rep. 2020 Nov 20;10(1):20258. doi: 10.1038/s41598-020-76927-0.
Sci Rep. 2020.
PMID: 33219264
Free PMC article.